Literature DB >> 1471889

Defective alloantigen-presenting capacity of 'Langerhans cell histiocytosis cells'.

R C Yu1, J F Morris, J Pritchard, T C Chu.   

Abstract

The functional activity of skin cells derived from an infant who died of multisystem Langerhans cell histiocytosis (LCH) was examined. Involved and non-involved skin was obtained at postmortem examination within three hours of death; normal epidermal Langerhans cells and 'LCH cells' were separated by means of dispase digestion. The functional activity of different populations of CD1a positive cells was assessed using the conventional six day allogeneic mixed cell reaction. Compared with Langerhans cells from a healthy control, LCH cells showed minimal functional activity. However, Langerhans cells from non-involved skin showed normal and Langerhans cells overlying involved skin showed augmented functional activity. These findings suggest that LCH is a disease in which abnormal Langerhans cells accumulate and/or proliferate in various tissues but it does not affect the entire Langerhans cell population.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1471889      PMCID: PMC1793774          DOI: 10.1136/adc.67.11.1370

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  10 in total

1.  Ia antigen expression on human epidermal Langerhans cells.

Authors:  G Rowden; M G Lewis; A K Sullivan
Journal:  Nature       Date:  1977-07-21       Impact factor: 49.962

Review 2.  Lymphoid dendritic cells.

Authors:  J M Austyn
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

3.  Histiocytosis syndromes in children.

Authors:  T Chu; G J D'Angio; B E Favara; S Ladisch; M Nesbit; J Pritchard
Journal:  Lancet       Date:  1987-07-04       Impact factor: 79.321

4.  Enriched epidermal Langerhans cells are potent antigen-presenting cells for T cells.

Authors:  S Bjercke; J Elgø; L Braathen; E Thorsby
Journal:  J Invest Dermatol       Date:  1984-10       Impact factor: 8.551

5.  A new immunologic marker for human Langerhans cells.

Authors:  G F Murphy; A K Bhan; S Sato; M C Mihm; T J Harrist
Journal:  N Engl J Med       Date:  1981-03-26       Impact factor: 91.245

6.  Histiocytosis X. Purified (T6+) cells from bone granuloma produce interleukin 1 and prostaglandin E2 in culture.

Authors:  F Arenzana-Seisdedos; S Barbey; J L Virelizier; M Kornprobst; C Nezelof
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

7.  The phenotypic spectrum of histiocytosis X cells.

Authors:  V Groh; H Gadner; T Radaszkiewicz; K Rappersberger; K Konrad; K Wolff; G Stingl
Journal:  J Invest Dermatol       Date:  1988-04       Impact factor: 8.551

8.  A flow cytometric study of Langerhans cell histiocytosis.

Authors:  J McLelland; J Newton; M Malone; R S Camplejohn; A C Chu
Journal:  Br J Dermatol       Date:  1989-04       Impact factor: 9.302

9.  Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen-presenting cell) requirements for growth and lymphokine release.

Authors:  K Inaba; R M Steinman
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

10.  Immunologic properties of purified epidermal Langerhans cells. Distinct requirements for stimulation of unprimed and sensitized T lymphocytes.

Authors:  K Inaba; G Schuler; M D Witmer; J Valinksy; B Atassi; R M Steinman
Journal:  J Exp Med       Date:  1986-08-01       Impact factor: 14.307

  10 in total
  7 in total

Review 1.  The normal Langerhans cell and the LCH cell.

Authors:  T Chu; R Jaffe
Journal:  Br J Cancer Suppl       Date:  1994-09

2.  Expression of cellular adhesion molecules in Langerhans cell histiocytosis and normal Langerhans cells.

Authors:  J H de Graaf; R Y Tamminga; W A Kamps; W Timens
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

3.  Presence of circulating abnormal CD34+ progenitors in adult Langerhans cell histiocytosis.

Authors:  L Misery; N Rougier; B Crestani; M Faure; A Claudy; D Schmitt; C Vincent
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

4.  Functional defect in cells involved in Langerhans cell histiocytosis.

Authors:  R C Yu; M Alaibac; A C Chu
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

5.  AA amyloidosis in a patient with Langerhans cell histiocytosis.

Authors:  Peter C Thomson; Alison H M Taylor; Scott T W Morris; David Kipgen; Robert A Mactier
Journal:  NDT Plus       Date:  2011-02-01

Review 6.  Langerhans cells and their role in oral mucosal diseases.

Authors:  Juhi Upadhyay; Ram B Upadhyay; Pankaj Agrawal; Shweta Jaitley; Rhitu Shekhar
Journal:  N Am J Med Sci       Date:  2013-09

7.  Langerhans cell histiocytosis of the maxillae in a child treated only with chemotherapy: a case report.

Authors:  Angela Pia Cazzolla; Giuseppe Troiano; Khrystyna Zhurakivska; Eugenio Maiorano; Gianfranco Favia; Maria Grazia Lacaita; Giuseppe Marzo; Franca Dicuonzo; Stefano Andresciani; Lorenzo Lo Muzio
Journal:  J Med Case Rep       Date:  2017-05-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.